表紙:ライフサイエンスツールの世界市場 - 市場規模、シェア、成長分析:製品タイプ別、エンドユーザー別 - 業界予測(2022年~2028年)
市場調査レポート
商品コード
1270676

ライフサイエンスツールの世界市場 - 市場規模、シェア、成長分析:製品タイプ別、エンドユーザー別 - 業界予測(2022年~2028年)

Global Life Science Tool Market Size, Share, Growth Analysis, By Product Type(PCR & QPCR, Separation Technologies), By End-User(Healthcare, Biopharmaceutical) - Industry Forecast 2022-2028

出版日: | 発行: SkyQuest | ページ情報: 英文 248 Pages | 納期: 3~5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ライフサイエンスツールの世界市場 - 市場規模、シェア、成長分析:製品タイプ別、エンドユーザー別 - 業界予測(2022年~2028年)
出版日: 2023年04月19日
発行: SkyQuest
ページ情報: 英文 248 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 目次
概要

世界のライフサイエンスツールの市場規模は、2022年の1,440億8,000万米ドルから2030年までに3,306億9,000万米ドルに達し、予測期間(2023年~2030年)にCAGRで10.8%の成長が予測されています。業界は、研究開発活動の活発化、技術の進歩、個別化医療に対する需要の向上によって牽引されています。

当レポートでは、世界のライフサイエンスツール市場について調査分析し、市場力学と見通し、セグメント分析、企業プロファイルなどを提供しています。

目次

エグゼクティブサマリー

調査手法

親市場の分析

主な市場の考察

  • 技術分析
  • 価格分析
  • サプライチェーン分析
  • バリューチェーン分析
  • 市場のエコシステム
  • IP分析
  • 貿易分析
  • スタートアップ分析
  • 原材料の分析
  • イノベーションマトリックス
  • パイプライン製品の分析
  • マクロ経済指標
  • 主な投資の分析
  • 主な成功要因
  • 競合の程度

市場力学と見通し

  • 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
  • 規制情勢
  • ポーターのファイブフォース分析
  • 将来の混乱についての特別な考察

世界のライフサイエンスツール市場:製品タイプ別

  • 市場の概要
  • PCR・QPCR
  • 分離技術
  • 核酸マイクロアレイ
  • その他の技術

世界のライフサイエンスツール市場:エンドユーザー別

  • 市場の概要
  • 医療
  • バイオ医薬品
  • 学術
  • 政府
  • その他

世界のライフサイエンスツールの市場規模:地域別

  • 市場の概要
  • 北米
  • 米国
  • カナダ
  • 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • その他の欧州
  • アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋
  • ラテンアメリカ
  • ブラジル
  • その他のラテンアメリカ
  • 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他の中東・アフリカ

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2021年)
  • 主要市場企業が採用した戦略
  • 主な成功戦略
  • 市場における最近の活動
  • 主要企業の市場シェア(2021年)

主要企業プロファイル

  • PerkinElmer Inc. (US)
  • General Electric Company (US)
  • Danaher (US)
  • Thermo Fisher Scientific (US)
  • Agilent Technologies Inc. (US)
  • Qiagen (Germany)
  • Shimadzu Corporation (Japan)
  • Becton Dickinson and Company (US)
  • Merck KGAA (Germany)
目次
Product Code: SQSG35J2006

Life Science Tool Market size was valued at USD 130 billion in 2021 and is poised to grow from USD 144.08 billion in 2022 to USD 330.69 billion by 2030, growing at a CAGR of 10.8% in the forecast period (2023-2030).

The global life science tool market is a rapidly growing industry that provides scientific researchers with essential equipment and technology needed for a variety of applications, such as genomics, proteomics, and drug discovery. The market includes a range of products and services, such as instruments, reagents, software, and lab services. This industry is driven by increasing research and development activities, technological advancements, and the rising demand for personalized medicine. The market is expected to continue its growth trajectory in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of Life Science Tool market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

The Life Science Tool market has been segmented based on product2 type, end-user, and region. By product type, the market is segmented as PCR & qPCR, separation technologies, nucleic acid microarray, and other technologies. Based on the end-user are classified as healthcare, biopharmaceutical, academics and government, and Others. Based on region, Life Science Tool is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Driver

The life science instruments market is experiencing notable growth due to the rapid technological advancements made by businesses in fields such as sequencing technologies, mass spectrometry, NMR, and chromatography methods, among others. Market players are also increasing their investments in research and development for products and services related to life sciences, while simultaneously entering into more strategic agreements, further driving innovation and growth in the market.

Restrain

The life science software market faces obstacles that are impeding its growth, including expensive implementation costs, complex programming requirements, infrastructure demands, and the costs of managing data.

Trend

The straightforward approval processes for a range of life science tools, in contrast to medicines and medical devices, are expected to benefit the market in the near future. This will result in an abundance of life science tools available in the market, which can help combat the widespread occurrence of infectious diseases. These instruments are crucial in identifying, comprehending, and monitoring disease progression, and are expected to drive the global market in the coming years. Furthermore, ongoing technological advancements and enhancements in the production of life science tools are also expected to promote the growth of the global market.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune
  • Research Methodology
  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
  • Market Dynamics & Outlook
  • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Regulatory Landscape
  • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Life Science Tool Market by Product Type
  • Market Overview
  • PCR & QPCR
  • Separation Technologies
  • Nucleic Acid Microarray
  • Other Technologies
  • Global Life Science Tool Market by End-User
  • Market Overview
  • Healthcare
  • Biopharmaceutical
  • Academics
  • Government
  • Others
  • Global Life Science Tool Market Size by Region
  • Market Overview
  • North America
  • USA
  • Canada
  • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
  • Latin America
  • Brazil
  • Rest of Latin America
  • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
  • By Development
  • By Company
  • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
  • Key Company Profiles
  • PerkinElmer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • General Electric Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Danaher (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Agilent Technologies Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Qiagen (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Shimadzu Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Becton Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Merck KGAA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments